Roblox Stock Upgraded to Buy as Growth Outlook Strengthens
Roth Capital upgrades Roblox to Buy with an $84 price target, citing strong bookings growth, improved game quality, and rising older player engagement.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Roth Capital upgrades Roblox to Buy with an $84 price target, citing strong bookings growth, improved game quality, and rising older player engagement.
President Trump endorses Nexstar's $6.2B Tegna acquisition, reversing earlier criticism. Deal would create largest local TV operator covering 80% of U.S. households.
Cleveland-Cliffs reports Q4 2025 losses but sees brighter 2026 outlook. POSCO partnership negotiations extended to first half 2026. Stock drops 19% on disappointing results.
Playboy (PLBY) shares jump 28% as company announces $122 million deal to sell half its China business to UTG Brands Management Group, with proceeds earmarked for debt reduction.
AppLovin shares rise after CapitalWatch corrects claims about major shareholder Hao Tang while maintaining its negative outlook on the company's financial structure.
Wedbush gives Zura Bio an Outperform rating and $15 target, highlighting upcoming clinical catalysts and potential stock growth through 2026.